针对患者量身定制的支架:我们还在吗?
Piotr Arski1, Jakub M Zimodro1, Magda Mucha2
11st Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Cardiology journal
|June 12, 2025
概括
选择正确的冠状动脉支架是穿皮冠状动脉干预成功的关键. 本综述指导了基于患者因素和特定临床情景的支架选择,以改善结果.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 生物材料科学 生物材料科学
背景情况:
- 穿皮冠状动脉干预 (PCI) 是一种标准的重血管化方法.
- PCI的结果取决于患者和程序因素.
- 冠状动脉支架技术已经从裸金属支架发展到多代药物释放支架 (DES) 和新型设计.
研究的目的:
- 审查各种冠状动脉支架的有效性和安全性.
- 在特定的临床和程序场景中制定针对患者量身定制的支架选择策略.
主要方法:
- 对冠状动脉支架性能现有证据的系统审查.
- 分析支架特征,包括聚合物类型,药物化和支架厚度.
- 评估不同患者群体和病变复杂性的结果.
主要成果:
- 特定的支架类型在各种环境中表现有前途:用于小容器的西罗利斯排泄支架 (SES),用于多容器PCI的可生物降解聚合物SES,用于分叉的常利斯排泄支架 (EES) 和罗利斯排泄支架,用于慢性全闭支架的EES.
- 对于糖尿病患者,建议使用SES,EES和无聚合物支架. 超薄生物降解聚合物DES和氧化涂层支架已被用于急性冠状动脉综合征.
- 无聚合物生物释放支架可能有利于高出血风险患者.
结论:
- 目前的证据支持在特定场景中为PCI成功量身定制的支架选择.
- 需要进一步的随机试验来巩固最佳冠状动脉支架使用的建议.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


